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Abstract
Key to understanding the epidemiology and pathogenesis of prion diseases, including chronic wasting disease (CWD) of
cervids, is determining the mode of transmission from one individual to another. We have previously reported that saliva
and blood from CWD-infected deer contain sufficient infectious prions to transmit disease upon passage into naı ¨ve deer.
Here we again use bioassays in deer to show that blood and saliva of pre-symptomatic deer contain infectious prions
capable of infecting naı ¨ve deer and that naı ¨ve deer exposed only to environmental fomites from the suites of CWD-infected
deer acquired CWD infection after a period of 15 months post initial exposure. These results help to further explain the basis
for the facile transmission of CWD, highlight the complexities associated with CWD transmission among cervids in their
natural environment, emphasize the potential utility of blood-based testing to detect pre-clinical CWD infection, and could
augur similar transmission dynamics in other prion infections.
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Introduction
Chronic wasting disease (CWD) is a fatal transmissible spongi-
form encephalopathy (TSE), or prion disease, marked by a high
transmission efficiency among cervids. Since its identification in
cervid populations of northern Colorado and southeastern Wyom-
ing [1–3], CWD has now been identified in 15 states, 2 Canadian
provinces, and one Asian country [4–6]. Captive deer studies and
epidemiological models of CWD prevalence and risk, suggest that
the facile transmission of CWD between cervids occurs primarily by
horizontal/lateral means [7–10]. CWD in farmed and free-ranging
cervids has caused substantial economic, ecological, trade, and
cultural impact and carries with it the potential for human and
domestic animal health risk [11–20]. The latter, while at present
theoretical, is shaped by the occurrence of human variant Creutzfelt
Jacob Disease (vCJD) arising from consumption of bovine
spongiform encephalopathy (BSE) [21–23] contaminated beef
[24]. As with BSE, humans appear to be separated from CWD
by a demonstrable species barrier [25,26]. Nevertheless, the
presence of infectious prions in the saliva and blood of terminal
CWD-infected deer [27] provide a possible mechanism for natural
transmissionamongcervidsandprovideanexposurerisktohumans
anddomesticlivestock.Additionally,demonstrated CWDinfectivity
in saliva and blood raises questions regarding the potential for
horizontal transmission of other prion infections, especially during
the subclinical or pre-symptomatic phase of disease as has been
reported with blood transfusion of human vCJD [28–30], sheep
scrapie [31,32], and BSE infection [33–35].
We undertook the present studies to confirm our earlier findings
on prion excretion through bioassays in white-tailed deer, but also
to determine: (a) whether CWD prions are present in body fluids
and excretions during the pre-clinical phase of infection, and (b)
whether repeated environmental fomite exposure alone, vs. direct
animal-to-animal contact, was sufficient to transmit CWD in deer.
Results
Detection of CWD infection in exposed animals
Blood (cohort 1). Each naı ¨ve deer received blood by the IV
route from pre-clinical CWD+ source deer that were 10–12
months post inoculation (pi) (Tables 1, 2). Two of three recipient
deer became PrP
CWD tonsil biopsy positive at 12 months pi, but
not at earlier sampling intervals (Fig. 1). At 19 months pi, when the
cohort was necropsied, all three deer were CWD+, as indicated by
detection of PrP
CWD in the medulla oblongata at the level of the
obex (medulla at obex) and in lymphoid tissue (Fig. 2).
Saliva (cohort 2). Each of the 3 deer in this cohort received
saliva from pre-clinical CWD+ donors that were 6 to 13 months pi
(Tables 1, 2). PrP
CWD was detected in tonsil of 1 of the 3
inoculated deer at 12 months pi, but not at earlier time points. By
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detection of PrP
CWD in brain and lymphoid tissue. The remaining
deer was of necessity terminated at 16 months pi due to
unmanageable aggressive behavior. This animal was CWD
negative as determined by extensive western blot and IHC
analysis (Figs. 1, 2).
Urine/feces (cohort 3). Each of the 3 deer received
repeated (90 daily) oral doses of urine and feces from CWD+
source deer ranging from pre-clinical to advanced clinical disease
(Tables 1, 2). All of the recipient deer remained PrP
CWD-negative
throughout the 19-month study course (Table 1, Figs. 1, 2).
Environmental exposure (cohort 4). The two animals in
this cohort were exposed to daily introductions of feed buckets,
water, and bedding removed from pens housing deer transitioning
from pre-clinical to clinical phases of the disease (Table 1, 2). One
of 2 exposed deer became tonsil biopsy PrP
CWD-positive at 15
months pi. At study termination, 19 months pi, both animals were
CWD+ (Figs. 1, 2).
Positive controls (cohort 5). After oral inoculation with
CWD+ brain homogenate, PrP
CWD was detected in the tonsil of 4
of 4 inoculated deer at either 6 (n=2), or 12 months (n=2) pi
(Figs. 1, 2 and Tables 1, 2).
Clinical signs of CWD
Project-dedicated caretakers intimately familiar with each
animal observed the deer daily. Subtle clinical signs consistent
with CWD were detected 12–20 months pi in 3 of 4 positive
control animals (cohort 5), 2 of 3 animals receiving blood
transfusion (cohort 1) and 1 of 3 deer orally inoculated with saliva
(cohort 2). Clinical disease onset manifested primarily as perceived
body muscle-mass reduction and gradual weight loss, which
reached $20% of maximum body weight over 2 to 8 months.
Other clinical signs included: rough hair coat due to piloerection
and a body stance characterized by a low head position and wide
leg stance. Changes in behavior included hyperphagia and
polydipsia despite weight loss, and stereotypic movements
including head tossing, repetitive and exaggerated lifting of the
legs, diminished alertness, and occasionally aggressive behavior in
the advanced stage of disease. Animals were euthanized when they
displayed advanced clinical signs of CWD or at 19 months pi.
Detection of PrP
CWD in tissues at necropsy
Nineteen months after inoculation, all animals testing CWD2
by tonsil biopsy in cohorts 1–4 were euthanized and necropsied.
Two of 4 cohort 5 (positive control) deer and 2 of 3 cohort 1
(blood) tonsil-biopsy-positive deer were euthanized due to
advanced clinical signs of CWD at 13, 24, 26 and 29 months pi,
respectively. Earlier studies established that medulla at obex, tonsil
and retropharyngeal lymph node had highest frequency of
PrP
CWD deposition in infected deer [36]. Therefore, these tissues
were rigorously examined in all animals. The results of
Table 2. CWD bioassay inocula sources.
Animal cohort Inoculum Donor animal (n inoculated)
Donor animal
clinical status
Donor animal
mo. pi.
1 Whole blood CSU Yr I 112
b (2) Pre-clinical 10–12
CSU Yr I 121
c (1)
2 Saliva CSU Yr I pool 112+121 (3) Pre-clinical 6–13
3 Urine and feces CSU Yr I pool 112+121 (3) Transitioning
f 3–24
4 Environmental contact
a CSU Yr I 121, 104, 106 (2) Transitioning
f 3–24
5 Brain WDNR
d (2) Mixed
g Terminal
CSVDL TS 989
e (2) Pre-clinical
aWater, feed buckets and bedding from CWD+ deer suites.
bColorado State University deer number 112 (PO brain inoculated deer from previous study[27]).
cColorado State University deer number 121 (IC brain inoculated deer from previous study [27]).
dWisconsin Department of Natural Resources, Madison, WI, USA.
eColorado State Veterinary Diagnostic Laboratory, Fort Collins, CO, USA.
fTransitioning from pre-clinical to clinical.
gContains brain tissue from deer of pre-clinical and clinical status at terminal field collection.
doi:10.1371/journal.pone.0005916.t002
Table 1. CWD bioassay inoculation cohorts.
Animal
cohort n Inoculum
Route of
inoculation Dosage (total volume) No. of inoculations
Prnp codon 96
genotype n GG/
n GS
1 3 Whole blood IV 1 (225 ml) 1 2/1
2 3 Saliva PO 10 ml/day for 5 days (50 ml) 5 3/0
3 3 Urine and Feces PO 90 daily doses (85 ml+112.5 gr) 90 3/0
4 2 Environmental contact
a PO 19 mos. continuous exposure Refreshed daily for 570
days (19 mos.)
1/1
5 4 Brain PO 1 gr/day for 5 days (5 gr) 5 2/2
aWater, feed buckets and bedding from CWD+ deer suites.
doi:10.1371/journal.pone.0005916.t001
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PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5916immunohistochemistry (IHC) and western blot (WB) assays for
PrP
CWD correlated with each other and with previous positive
tonsil-biopsy results in 10 of 13 animals (Fig. 1). In 3 animals,
however, (one each in the blood, saliva and positive control
inoculation cohorts) in which previous tonsil biopsies had been
negative, PrP
CWD was detected in tonsil, retropharyngeal
lymphoid tissues and brain collected at necropsy (Fig. 1). Western
blot analysis confirmed IHC results (Fig. 2) in all cases, and
demonstrated the characteristic proteinase K-resistant 28–35 kd
bands typical of PrP
CWD (Fig. 3).
Discussion
Time interval to detection of CWD infection by tonsil
biopsy
The high transmission rate of CWD among cervids in their
natural environment sets CWD apart from other prion diseases.
The results of this study help provide a plausible basis for this facile
transmission and extend our earlier findings [27] (Fig. 4) in
demonstrating infectious prions in blood and saliva of pre-clinical
CWD+ donors. The time from exposure to first detection of
Figure 1. PrP
CWD detection by longitudinal tonsil biopsy and terminal necropsy.
doi:10.1371/journal.pone.0005916.g001
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CWD by tonsil biopsy was variable—as short as 6 months but as
long as 18 months. We assume that the time until appearance of
PrP
CWD in tonsil is an underestimate due to the inherent
variability in prion deposition kinetics [36] and the logistical
limitations of tonsil biopsies, which require general anesthesia. The
incubation periods prior to clinical CWD in our study were similar
to those observed previously in experimental and naturally
acquired infections [27,37,38]. While we can not exclude
horizontal transmission from the first positive deer in each cohort,
the timeframe for detection in the remaining deer (3 months) is less
than half that which we have historically observed in deer
inoculated orally with a brain homogenate from terminal CWD-
infected deer [27], suggesting much earlier exposure to infectious
prions.
Infectious prions in saliva of CWD+ deer
The presence of infectious CWD prions in saliva suggests the
potential for disease transmission via grooming interactions,
shared water sources and communal feeding grounds—especially
in high density cervid populations, such as those that exist for some
cervid species during the breeding season, at baiting sites, in
captivity, and in low predation situations. Other investigators have
detected the presence of the aberrant misfolded prion protein
(PrP
RES) in alimentary tract tissue, and have suggested saliva as a
possible vehicle for prion transmission [27,37,39,40]. While the
volume of saliva used in this study was large, the results
nevertheless provide evidence to support the above premise.
Salivary dissemination of prions may not be limited to CWD.
Prions associated with transmissible mink encephalopathy (TME)
have been detected in the submandibular salivary gland of mink
[41] and TME protease-resistant prion protein has been detected
in the lamina propria of the oral cavity, taste buds and squamous
epithelium of the tongue, and the vomeronasal organ and
olfactory mucosa of infected hamsters [40]. Hamster-adapted
scrapie agent has been found in the tongue and taste buds of
prion-infected hamsters [42]. Vascellari et al reported the presence
Figure 2. Immunohistochemistry results of deer exposed to body secretions and excreta from CWD+ deer. PrP
CWD demonstrated by
immunohistochemistry in tonsil, brain (medulla oblongata at obex), and retropharyngeal lymph node of deer receiving saliva, blood, or
environmental exposure from CWD-infected donors. CWD immunohistochemistry is shown in the medulla at obex (a–j) and either tonsil or
retropharyngeal lymph node (k–t). Arrows indicate PrP
CWD staining (red) within brain and lymphoid follicles. Arrow with * indicates lymphoid follicle
negative for PrP
CWD.
doi:10.1371/journal.pone.0005916.g002
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glands of naturally and experimentally infected sheep [43], and we
have made similar observations in the olfactory mucosa of ferrets
experimentally infected with CWD [44] and in the taste buds of
deer (Haley, NJ, personal communication). The exact source of
prions shed in saliva remains speculative; possible sources include
centrifugal/retrograde passage from nerve fiber terminations in
the oral–nasal mucosa, or from lymphoid cells emanating from
infected tonsilar or other alimentary lymphoid tissues.
Infectious prions in blood of CWD+ deer
Blood-borne transmission of TSEs has long been feared, and the
identification of a prion pathogen associated with blood-borne
transmission has been pursued with disparate results [33,45,46].
Here we report the induction of CWD infection by a single blood
transfusion from each of two pre-clinical CWD+ blood donors.
This result is consistent with previous findings in substantiating the
transmission of infectious prions by the blood of asymptomatic
animal [27,32] and human [28–30,47,48] donors, thus providing
support for a subclinical hematogenous carrier state in TSE
infections.
Direct detection of blood-borne PrP
RES has been difficult. Saa et
al were the first to use protein misfolding cyclic amplification assay
(PMCA) [49,50] to detect protease-resistant prion protein in the
blood of asymptomatic scrapie-infected hamsters [51]. More
recently, Thorne et al reported PMCA amplification of PrP
SC from
the blood of scrapie-infected sheep [52]. Continued efforts toward
the development of sensitive, noninvasive, diagnostic tools are
paramount. We are presently re-examining by serial PMCA the
tissues of exposed but conventional PrP
CWD test negative animals
that may harbor infectious prions not manifested in the
observation periods used in our CWD studies.
Hunter and colleagues [33,34] provided the first evidence for
blood-borne TSE transmission for bovine spongiform encepha-
lopathy (BSE) and scrapie by transfusion of whole blood [33,34]
and buffy-coat white blood cells [34] from infected donor sheep to
naı ¨ve sheep. Sparse but compelling evidence has accumulated for
blood transmission of variant Creutzfeldt-Jakob Disease (vCJD)
[28–30,48] and PrP
RES has been found in peripheral organs of
some sporadic CJD patients [53], raising the possibility that
peripheral distribution of PrP
RES is not limited to vCJD. In an
ongoing study of sixty-six individuals who received blood products
from asymptomatic blood donors who later developed vCJD [54],
three of the 66 blood transfusion recipients developed vCJD 6.5 to
8.5 years after receiving blood [28,30,48] and a fourth blood
recipient died of causes unrelated to vCJD five years after
receiving the blood donation. Upon autopsy of this individual,
PrP
RES was detected in lymphoid tissue but not brain, thus
providing presumptive evidence for a case of subclinical infection
[29]. Our findings with CWD further support the tenet that blood
products from subclinical prion-infected individuals may transmit
disease.
Additional cases of subclinical human prion disease may exist.
While in vitro conversion studies have indicated an inefficient
conversion of human PrP into a protease-resistant form [26,55]
and no evidence exists of CWD transmission to non-cervid species
cohabitating with or on CWD contaminated environments
[24,56–58], it is reasonable to surmise that cross-species
transmission of prions may require extenuating circumstances,
i.e. origin of specific strains [59,60], prolonged incubation time
[61], and permissive genotypes [62]. At least two studies provide
information bearing on these concerns. The first study, an ongoing
longitudinal study to closely monitor 81 Americans who
inadvertently consumed, or were exposed to, CWD+ venison at
an upstate New York sportsman’s feast, will conduct health
evaluations of these individuals over the next six years [63]. The
second, a retrospective study using western blot analysis of human
tonsil and appendix samples collected in the United Kingdom
Figure 3. Western blot results of deer exposed to body secretions and excreta from CWD+ deer. Western blot demonstration of the
typical PK digestion band shift (28–35 kD) associated with prion infection in the brain (medulla oblongata at obex) of deer receiving blood, brain,
saliva or environmental exposure, but not urine and feces from CWD-infected donors. Lanes 1–4 represent CWD+/2 deer controls (10% brain
homogenate of medulla at obex) without and with PK digestion at 25 mg/ml. Lanes 5–12, 10% brain homogenate of blood, brain, urine/feces or saliva
inoculated deer without and with PK digestion at 25 mg/ml. Lanes 13–15, brain homogenate from deer environmentally exposed to CWD+ fomites
without and with PK digestion at 25 and 50 mg/ml.
doi:10.1371/journal.pone.0005916.g003
Infectious CWD
PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5916Figure 4. Summary of naı ¨ve deer exposed to inoculum from CWD+ deer—combined with our previous published findings [27].
doi:10.1371/journal.pone.0005916.g004
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the detection of abnormal prion protein in three of 12,674 samples
[64]. Mathematical modeling based on the results of this study
predicts a minimum estimate of 3000 BSE infected people in the
UK between 10–30 years of age. If this model is accurate, it
predicts that 93% of these individuals could develop long-term
subclinical infection [65].
Environmental sources of CWD infection
Previous studies have confirmed direct animal-to-animal
contact—horizontal transmission—as an efficient mode for prion
disease transmission [9,66]. Moreover, Miller and colleagues
[9,67,68] have provided substantial evidence for environmental
contamination as a source of CWD infection. Our bioassay study
inocula doses (50 ml saliva/deer), while efficient in establishing the
infectious nature of saliva, are likely unrealistic doses to be
acquired in a natural setting. To emulate a more feasible natural
environment-associated dose, while negating direct animal-to-
animal contact, we exposed naı ¨ve deer to repeated exposures to
fomites from the suites of CWD-infected deer. The study design
was meant to mirror the daily habits and movements of a deer in
its natural setting in which it may return to an area contaminated
with small amounts of infectious prions over time. Here we
provide the first report that under controlled indoor conditions
CWD-naı ¨ve deer can acquire infection by exposure to fomites
from the environment of CWD-infected deer, supporting the
findings of Miller et al in the natural environment [9,67,68], in
demonstrating that there are sufficient infectious prions in bedding
and water to transmit CWD. Efficient transmission, as evidenced
by tonsillar lymphoid PrP
CWD detection, was seen in as little as 15
months post initial exposure. These results are also consistent with
the findings of Georgsson [69] and Miller [67] as part of their
attempts to decontaminate areas heavily contaminated with
scrapie and CWD. Animals reintroduced to these areas after
decontamination developed clinical signs of prion disease within
two years. The presence of infectious CWD prions in the
environment therefore strongly suggests that natural prion
infection occurs by routes additional to direct animal-to-animal
contact. Based on the present and our previous findings [27], we
speculate that saliva may harbor the greatest concentration of
CWD prions available for horizontal transmission and environ-
mental contamination, but recognize that other routes of excretion
at lower concentration and greater volume still remain plausible.
Lack of detectable infectious prions in the urine and
feces of CWD+ deer
Previous studies have postulated that environmental contami-
nation by excreta from infected cervids seems the most plausible
explanation for the dissemination of CWD [70], yet at 19 months
pi we were not able to detect PrP
CWD in the three deer inoculated
with urine and feces. Our earlier report [27] indicated that 2 of 2
deer expressing the prnp gene G/S polymorphism at codon 96
remained negative 19 mo. pi. In the present study all three deer
inoculated with urine and feces expressed the G/G polymorphism
at prnp codon 96, which is associated with susceptibility to CWD
infection [71]. We report no detection of PrP
CWD in the obex or
lymphoid tissues of deer with either G/G or G/S polymorphisms
at 19 mo pi. Although both of our bioassay studies in deer have
failed to transmit CWD infection by oral exposure to urine and
feces from CWD-infected deer, these results must still be
interpreted with caution in light of ongoing PMCA and cervid
transgenic mouse intracerebral bioassay studies which suggest that
very low concentrations of prions may be present in urine and
feces of CWD+ cervids [72–74]. Perhaps an incubation time
longer than 19 months is necessary for a detectable accumulation
of lymphoid PrP
CWD, or a larger dose of inoculum by the oral
route is necessary for efficient passage of prions across the
alimentary mucosa.
In summary, the results reported here reconfirm that blood and
saliva are sources of infectious CWD prions, consistent with
previous findings [27], and further support a mechanism for
efficient CWD transmission in nature. We also show that
infectious prions shed into the environment by CWD+ deer are
sufficient to transmit the disease to naı ¨ve deer in the absence of
direct animal-to-animal contact. These observations reinforce the
exposure risk associated with body fluids, excreta, and all tissues
from CWD+ cervids and suggest that similar dynamics may exist
in other prion infections.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by relevant national and/or local animal
welfare bodies, and all animal work was approved by Colorado
State University Animal and Care Use Committee (ACUC
approval number 08-175A-01).
White-tailed deer
White-tailed deer fawns were provided by the Warnell School of
Forestry and Natural Resources, University of Georgia, Athens
(UGA)—a region where CWD has not been detected. The deer
fawns were hand-raised and human and indoor-adapted before
overnight transport directly to the Colorado State University
(CSU) CWD research indoor isolation facility without contact with
the native Colorado environment. The 4-month-old fawns were
adapted to the facility housing conditions and diet for 2 months
before study start.
Genotyping
All white-tailed deer were genotyped to determine GG/GS
(codon 96) status by the laboratory of Dr. Katherine O’Rourke,
USDA-ARS, Pullman, WA.
Biocontainment protocols
Protocols to preclude extraneous exposure and cross-contami-
nation between cohorts of animals as previously described [27]
incorporated protective shower-in requirements, Tyvek
TM cloth-
ing, masks, head covers, and footwear, while maintaining stringent
husbandry. Tonsil biopsy and terminal sample collections were
taken with animal-specific biopsy and sample collection instru-
ments to minimize possibility of cross contamination. Bedding and
liquid waste from each suite was either incinerated or collected in a
dedicated outdoor underground holding tank and denatured by
alkaline digestion.
Inoculation cohorts
Groups of n=2 to 4 six-month-old fawns (Table 1) were housed
in separate isolation suites throughout the study. Suite-dedicated
protective clothing, utensils, and waste disposal were incorporated
to exclude cross contamination by fomites, bedding, food,
excretions, or contact.
Inocula (route of inoculation; volume of inocula; months
pi of donor animals)
The following inocula were used: Blood (intravenous- IV; 1
transfusion of 225 ml; 10–12 mo pi), saliva (oral- PO; 10 ml/day
Infectious CWD
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sample collections of pre-clinical CWD-inoculated, tonsil biopsy
positive deer, while urine and feces (PO; 90 daily doses totaling
85 ml urine+112.5 gr feces; 3–24 mo pi) were obtained from serial
sample collections of pre-clinical and clinical CWD-inoculated,
tonsil biopsy positive deer housed in the CSU CWD isolation
facility[27]. Positive control brain (PO; 1 gr/day for 5 days=5 gr
total; terminal field samples) homogenates (medulla oblongata at
the level of the obex) that were confirmed as CWD+ by
immunohistochemistry (IHC) were from one of two sources–
either free-ranging white-tailed deer collected by the Wisconsin
Department of Natural Resources (WDNR) (n=2) or a free-
ranging mule deer utilized in a previous bioassay study[27]
provided by the Colorado State Veterinary Diagnostic Laboratory
(CSVDL) (n=2). For the environmental exposure study, water,
feed buckets, and bedding were collected on a daily basis from
CWD+ deer (3 to 24 months pi) that were part of ongoing studies
in the CSU CWD research facility. The cohort of environmentally
exposed deer was in uninterrupted contact with a continually
refreshed supply of CWD+ fomites for 19 months (Table 2).
Monitoring and sample collection
All animals were monitored for evidence of CWD infection by
serial tonsil biopsies taken at 3, 6, 12 months pi, and at study
termination. Tonsil tissue was divided and equal portions either
stored at 270uC or fixed in 10% formalin for 24 hours before
processing for IHC. At the same sampling intervals, blood, saliva,
feces, and urine were collected from each animal and stored at
270uC. At necropsy, palatine tonsils, brainstem (medulla at the
obex) and retropharyngeal lymph nodes, as well as other tissues,
were collected for examination by IHC and western blotting (WB)
to identify the presence of the protease-resistant prion protein
associated with CWD (PrP
CWD).
Western blotting
Tissue homogenates were prepared from the obex region of the
medulla oblongata encompassing the dorsal motor vagal nucleus
(medulla at the obex). Twenty percent (20%) w/v homogenates
were prepared in NP-40 buffer (10 mM Tris-HCl buffer pH 7.5,
0.5% NP-40, 0.5% sodium deoxycholate) by Fastprep
TM disrup-
tion at setting 6.5 for 45 seconds. Twenty-five ml of each
homogenate was mixed with 5 ml proteinase K (PK) (Invitrogen)
to a final concentration of 25 mg/ml and incubated for 30 minutes
at 37uC with shaking. Proteinase K activity was stopped with 4 ml
200 mM Pefablock SC and an equivalent volume of each sample
was mixed with 10 ml sample buffer (Invitrogen220% Reducing
agent 106, 50% LDS Sample buffer 46), 5 ml NP-40 buffer
(10 mM Tris-HCl pH 7.5, 0.5% deoxycholic acid, 0.5% non-
ylphenoxylpolyethoxylethanol), heated to 95uC for 5 minutes and
separated by 12% Bis-Tris precast polyacrylamide gel electropho-
resis (PAGE) (Invitrogen) at 150 volts for 2.5 hours in 16MOPS
(Invitrogen). PAGE separated proteins were transferred to
polyvinylidene fluoride (PVDF) membrane for 1 hour at 100 volts
in transfer buffer (0.025 M Trizma base, 0.2 M glycine, 20%
methanol, pH 8.3). After the PVDF membranes were blocked
overnight at room temperature in Pierce Blocker
TM they were
probed with the PrP specific antibody BAR224 (kindly supplied by
Dr. J. Grassi) followed by horse radish peroxidase (HRP)-goat anti-
mouse IgG diluted in Pierce Blocker
TM. Membranes were washed
for 1 hour after blocking and between antibodies with wash buffer
(0.1 M Tris, 0.15 M NaCl, 0.2% Tween 20 pH 8.0). To visualize
PrP bands the PVDF membranes were developed with the
Amersham
TM ECL detection system and a digital GelDoc
TM (Fuji
Intelligent dark box) using LAS-3000 Lite ImageReader software.
Immunohistochemistry (IHC) was performed by employing proto-
cols as described by Spraker et al [3]. Briefly, 3–5 mm sections of
formalin fixed formic acid treated tissues were deparafinized at
60–70uC for 1 hour, rehydrated via a series of xylene/ethanol
baths, and treated in formic acid a second time (5 minutes) prior to
a 20 minute antigen retrieval (Dako Target Retrieval Solution
106) cycle in a 2100 Retriever
TM (PickCell Laboratories). Slides
were further processed with the aid of a Ventana Discovery
TM
autostainer utilizing the Ventana Red Map
TM stain kit, the
PrP
CWD specific primary antibody BAR224 and a biotinylated
secondary goat anti mouse antibody (Ventana). After autostaining,
the slides were quickly rinsed in a warm water detergent solution,
passed through a series of dehydration baths and cover-slipped.
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